Mindfulness Based Couples Therapy
2 other identifiers
interventional
24
1 country
2
Brief Summary
The goal of this study is to explore the effects of a Mindfulness Based Couples Intervention on relationship satisfaction with quality of life and immune system function among breast cancer survivors and their partners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Jan 2015
Longer than P75 for not_applicable breast-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2015
CompletedStudy Start
First participant enrolled
January 23, 2015
CompletedFirst Posted
Study publicly available on registry
January 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedAugust 24, 2022
August 1, 2022
7.5 years
January 23, 2015
August 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of Mindfulness Based Couples Therapy Intervention Among Breast Cancer Survivors and Their Partners (intervention adherence rate, defined as the proportion of sessions completed out of a total of 8 sessions)
Feasibility endpoint is intervention adherence rate, defined as the proportion of sessions completed out of a total of 8 sessions.
12 weeks
Study Arms (2)
Mindfulness Based Stress Reduction Intervention (MBRE)
EXPERIMENTALParticipant and partner take part in an 8-week Mindfulness-Based Relationship Enhancement (MBRE) intervention course. MBRE course consists of meditation and yoga techniques and handouts. Pain assessment administered at baseline and at follow up visit. Questionnaires completed at baseline and at follow up visit. Neurocognitive tests administered at baseline and at follow up visit. Cortisol testing performed after baseline visit and at follow up visit. Interviews conducted after follow up visit. These interviews are audio-taped and transcribed.
Standard of Care
ACTIVE COMPARATORParticipants receive self-help materials that have been previously developed by MD Anderson's Office of Public Education, the American Cancer Society, and the National Cancer Institute. Pain assessment administered at baseline and at follow up visit. Questionnaires completed at baseline and at follow up visit. Neurocognitive tests administered at baseline and at follow up visit. Cortisol testing performed after baseline visit and at follow up visit. Interviews conducted after follow up visit. These interviews are audio-taped and transcribed.
Interventions
Participant and partner take part in an 8-week Mindfulness-Based Relationship Enhancement (MBRE) intervention course. MBRE course consists of meditation and yoga techniques and handouts.
Pain assessment administered at baseline and at follow up visit. Pain assessment involves submerging hand in cold water.
Questionnaires completed at baseline and at follow up visit. Questionnaires ask about fatigue, mood, stress, social support, marital satisfaction, depression, and general demographics (age, race and so on). It should take about 1½ hours total to complete the questionnaires.
Neurocognitive tests administered at baseline and at follow up visit. Tests to check memory and thinking abilities.
Cortisol testing performed after baseline visit and at follow up visit. Participants asked to collect saliva samples for cortisol assays immediately, 30, 45, and 60 minutes after awakening (representing the cortisol awakening response) and at noon, 4 P.M. and 8 P.M.
Interviews conducted after follow up visit. These interviews are audio-taped and transcribed.
Eligibility Criteria
You may qualify if:
- Stage 0-IIIA breast cancer survivors and their partner
- All the female breast cancer survivors will be at least two months from receiving cancer treatment (surgery, adjuvant therapy or radiation) and within three years from completing cancer treatment, except for tamoxifen/aromatase inhibitors.
- Are able to read and write in English
- Are able to pass the Physical Activity Readiness Questionnaire or participant provides a letter from their physician or nurse practitioner clearing them for study participation
- All couples co-habiting for at least 3 years with current partner who is willing to participate in study
- Are 21 years of age or older
You may not qualify if:
- Male breast cancer survivors;
- Participants with a diagnosis of diabetes, unless they are able to provide a letter from a physician who will continue to monitor the participant during the research study
- Anti-inflammatory medications (e.g. statins, cholesterol medication)
- Consume excessive amounts of alcohol (\>30 drinks/week)
- Pregnant or thinking about becoming pregnant during the study period
- Lactating women
- Major medical conditions involving the immune system such as autoimmune and/or inflammatory diseases
- Pressure readings \>/=140/90 mm Hg, as defined by the 7th Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, will be deemed ineligible to participate and excluded from the study. They will be referred to their family physician or community services. Those ineligible based on their initial blood pressure reading are allowed to participate if they provide a letter from a physician who will continue to monitor the participant during the research study.
- A hemoglobin level \< 10g/dl
- Person less than 21 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Lyndon B. Johnson General Hospital
Houston, Texas, 77026, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Dantzer, PHD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2015
First Posted
January 28, 2015
Study Start
January 23, 2015
Primary Completion
August 1, 2022
Study Completion
August 1, 2022
Last Updated
August 24, 2022
Record last verified: 2022-08